CRP and rheumatoid arthritis: Kuroda et al. [8] administered TNF-α inhibitors to 14 patients with AA amyloidosis secondary to RA (infliximab in 10 patients and etanercept in 4 patients) and reported a decrease of both CRP and SAA.